1-43282898-G-A
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 2P and 6B. PM2BP4_StrongBP6_Moderate
The NM_182517.3(C1orf210):c.229C>T(p.Arg77Cys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000359 in 1,614,046 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Consequence
NM_182517.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
C1orf210 | NM_182517.3 | c.229C>T | p.Arg77Cys | missense_variant | 3/3 | ENST00000523677.6 | NP_872323.1 | |
C1orf210 | NM_001164829.2 | c.229C>T | p.Arg77Cys | missense_variant | 3/3 | NP_001158301.1 | ||
C1orf210 | XM_011540802.3 | c.229C>T | p.Arg77Cys | missense_variant | 3/3 | XP_011539104.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
C1orf210 | ENST00000523677.6 | c.229C>T | p.Arg77Cys | missense_variant | 3/3 | 1 | NM_182517.3 | ENSP00000430918 | P1 | |
C1orf210 | ENST00000423420.1 | c.229C>T | p.Arg77Cys | missense_variant | 3/3 | 3 | ENSP00000429399 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000460 AC: 7AN: 152146Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000636 AC: 16AN: 251444Hom.: 0 AF XY: 0.0000736 AC XY: 10AN XY: 135896
GnomAD4 exome AF: 0.0000349 AC: 51AN: 1461782Hom.: 0 Cov.: 31 AF XY: 0.0000385 AC XY: 28AN XY: 727200
GnomAD4 genome AF: 0.0000460 AC: 7AN: 152264Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74462
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 13, 2021 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at